ArticleRadiology case reports2026
Microwave ablation as a minimally invasive treatment for primary hyperparathyroidism: A case report and literature review.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hyperparathyroidism (PHPT) is commonly caused by a solitary parathyroid adenoma and results in elevated parathyroid hormone (PTH) and calcium levels. While parathyroidectomy remains the gold standard, some patients are unsuitable for surgery due to comorbidities or personal preference. Percutaneous microwave ablation has emerged as a minimally invasive alternative in select cases. Microwave ablation uses thermal energy to induce localized necrosis of hyperfunctioning parathyroid tissue. Recent studies report cure rates exceeding 85%, with lower complication rates and faster recovery compared to surgery. We report a 33-year-old woman with biochemically confirmed PHPT who presented with fatigue, muscle weakness, and hypercalcemia. Despite meeting criteria for surgical intervention, the patient declined operative management. She underwent ultrasound-guided microwave ablation targeting a suspected parathyroid adenoma localized on a PET choline, Tc-99m Sestamibi Scintigraphy and 4D CT. The procedure was well-tolerated without complications. The microwave ablation was performed in October 2022. Postablation monitoring demonstrated normalization of serum calcium and PTH levels, with sustained biochemical remission and resolution of symptoms at follow-up. Over a 3-year follow-up period, she has maintained normocalcemia and normal PTH levels without recurrence of symptoms or need for surgery. Our findings suggest that microwave ablation is a feasible and promising option for managing PHPT in selected patients unwilling or unable to undergo parathyroidectomy, with a successful long-term biochemical response achieved in this patient after surgery was declined. This case adds to the expanding literature on microwave ablation as a viable alternative to surgery, particularly in individuals seeking less invasive treatment. Ongoing research and long-term data are needed to further define its role in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.